2 Department of Endocrinology, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, Peoples Republic of China Correspondence: Xinlu Yuan, Department of Endocrinology and Metabolic Diseases, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, Peoples Republic of China, Email [email protected] Abstract: Nonalcoholic fatty liver disease (NAFLD), as a multisystemic disease, is the most prevalent chronic liver disease characterized by extremely complex pathogenic mechanisms and multifactorial etiology, which often develops as a consequence of obesity, metabolic syndrome
8,9 Incretin therapies currently available in Australia Dulaglutide, liraglutide and semaglutide synthetic versions of human GLP-1 and tirzepatide, a single-molecule dual GLP-1 and GIP receptor coagonist, are available in Australia
Starting with PlexusDx's microdose GLP-1 protocol ($129/month) provides a gentler entry point for patients worried about side effects, with room to scale up as tolerance improves
What to Expect During Treatment Consultation Youll meet with a healthcare provider to assess your needs and determine the right dosage and frequency for your treatment
Kawata, T
Our medical team ensures every treatment is tailored to your skin type, lifestyle, and wellness goals
